References
- Atterholm, I., Hedström, S.-Å., Kahlmeter, G. & Kamme, C.: Tobramycin in patients with various infections: A clinical evaluation. Scand J Infect Dis 10:229, 1978.
- Bendush, C. L. & Weber, R.: Tobramycin sulfate: A summary of worldwide experience from clinical trials. J Infect Dis 134, Suppl. :S 219, 1976.
- Bergan, T. & Melby, K.: Amikacin og tobramycin. Tidsskr Nor Laegeforen 98:639, 1978.
- Blair, D. C, Fekety, F. R., Bruce, B., Silva. J. & Archer, G.: Therapy of Pseudomonas aeruginosa infections with tobramycin. Antimicrob Agents Chemother 8:22, 1975.
- Bruun, J. N. & Eng. J.: Clinical evaluation of tobramycin therapy in serious infections. J Oslo City Hosp. In press.
- Burkle, W. S.: Tobramycin and gentamicin: A comparison. Drug Intell Clin Pharm 10:43, 1976.
- Carmalt, E. D., Cortez, L. M. & Rosenblatt, J. E.: Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli. Am J Med Sei 271:285, 1976.
- Hoecker, J. L., Pickering, L. K., Swaney, J., Kramer, W. G., Eys, J.van, Feldman, S. & Kohl, S.: Clinical pharmacology of tobramycin in children. J Infect Dis 137:592, 1978.
- Kahlmeter, G., Hallberg, T. & Kamme, C.: Gentamicin and tobramycin in patients with various infections—concentrations in serum and urinary excretion J Antimicrob Chemother 4, Suppl. A: 37, 1978.
- — Gentamicin and tobramycin in patients with various infections-nephrotoxicity. J Antimicrob Chemo-ther 4, Suppl. A:47, 1978.
- Kahlmeter, G., Jonsson, S. & Kamme, C.: Multiple-compartment pharmacokinetics of tobramycin. J Antimicrob Chemother 4, Suppl. A: 5, 1978.
- Neu, H. C.: Tobramycin: An overview. J Infect Dis 135, Suppl.:S 3, 1976.
- Neu, H. C. & Bendush, C. L.: Ototoxicity of tobramycin: A clinical overview. J Infect Dis 135, Suppl.: S 206, 1976.
- Noone, P., Beale, D. F., Pollock, S. S., Perera, M. R., Amirak, I. D., Fernando. O. N. & Moorhead, J. F.: Monitoring aminoglycoside use in patients with severely impaired renal function. Br Med J 2:470, 1978.
- Noone, P., Parsons, T. M. C, Pattison, J. R., Slack. R. B. C., Garfield-Davis, D. & Hughes, K.: Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J 1:477. 1974.
- Ohtani, I., Ohtsuki, K., Omata, T., Ouchi, J. & Saito, T.: Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside an-tibiotics. ORL 40:53, 1978.
- Reiner, H. E., Bloxman, D. D. & Thompson, W. L.: Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs. J Antimicrob Chemother 4, Suppl. A: 85, 1978.
- Schentag, J. J., Cumbo, T. J., Jusko, W. J. & Plaut, M. E.: Gentamicin tissue accumulation and nephrotoxic reactions. JAMA 240: 2067, 1978.
- Schentag, J. J., Lasezkay, G., Plaut, M. E., Jusko. W. J. & Cumbo, T. J.: Comparative tissue accumulation of gentamicin and tobramycin in patients. J Antimicrob Chemother 4, Suppl. A: 23, 1978.
- Smith, C. R., Lipsky, J. J. & Lietman, P. S.: Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity. Antimicrob Agents Chemother 15:780, 1979.